Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Arna Pharma and Slate Run complete JV for new US company
  • M&A / Deals

Arna Pharma and Slate Run complete JV for new US company

Pharmaceutical Business Review

The companies are also launching their first collaboratively developed product, Aridol, and plan to introduce further branded products in the future.

Read full story

pharminent May 15, 2026 (Last updated: May 21, 2026)

Pharmaceutical Business Review

The companies are also launching their first collaboratively developed product, Aridol, and plan to introduce further branded products in the future.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Anthropic joins Gates Foundation on $200m health AI pledge
Next: Genmab drops 2 antibody assets, including another ProfoundBio ADC

Related Stories

  • M&A / Deals

J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout

pharminent July 31, 2026
  • M&A / Deals

Eisai and CORE Biomedicine agree on global licence for oncology pipeline

pharminent July 29, 2026
  • M&A / Deals

Argenx signs agreement to buy Forte Biosciences for $2.2bn

pharminent July 28, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.